Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.42)
# 3,376
Out of 4,906 analysts
51
Total ratings
53.12%
Success rate
-6.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Overweight | $147 → $142 | $124.42 | +14.13% | 6 | Jul 18, 2025 | |
| PODD Insulet | Maintains: Overweight | $305 → $322 | $280.96 | +14.61% | 4 | Feb 21, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $9.36 | +113.68% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $14.64 | +460.30% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $109.79 | +125.89% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $175.33 | +56.85% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $516.12 | -34.32% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.70 | +114.32% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $3.18 | +749.06% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $92.59 | +19.88% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $84.03 | +71.07% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $96.73 | -42.11% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $83.99 | -11.89% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $76.56 | +0.14% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $16.10 | +459.01% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $51.89 | - | 1 | Dec 12, 2019 |
Abbott Laboratories
Jul 18, 2025
Maintains: Overweight
Price Target: $147 → $142
Current: $124.42
Upside: +14.13%
Insulet
Feb 21, 2025
Maintains: Overweight
Price Target: $305 → $322
Current: $280.96
Upside: +14.61%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $9.36
Upside: +113.68%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $14.64
Upside: +460.30%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $109.79
Upside: +125.89%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $175.33
Upside: +56.85%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $516.12
Upside: -34.32%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.70
Upside: +114.32%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $3.18
Upside: +749.06%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $92.59
Upside: +19.88%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $84.03
Upside: +71.07%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $96.73
Upside: -42.11%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $83.99
Upside: -11.89%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $76.56
Upside: +0.14%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $16.10
Upside: +459.01%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $51.89
Upside: -